Thromboembolic event (DBCOND0024072)
Identifiers
- Synonyms
- Thromboembolic Events / Thromboembolic phenomena / Thromboembolic disorder (disorder) / Thromboembolism NOS / Embolism and thrombosis of unspecified site / Thromboembolism - lesion / Thromboembolism / Thromboembolus (morphologic abnormality) / Embolism / Embolism (& [post abortion]) / Embolism (disorder) / Embolism NOS
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Heparin An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation.- Antithrombin-IIItarget
- Coagulation factor Xtarget
- P-selectintarget
- Heparanaseenzyme
- Fibroblast growth factor receptor 4target
- Fibroblast growth factor 4target
- Fibroblast growth factor 19target
- Fibroblast growth factor receptor 1target
- Fibroblast growth factor 1target
- Fibroblast growth factor receptor 2target
- Fibroblast growth factor 2target
- Platelet factor 4target
- Hepatocyte growth factortarget
Nadroparin A low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction.- Protein c-Fostarget
- Myc proto-oncogene proteintarget
- P-selectintarget
- Antithrombin-IIItarget
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04115436 Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation No drug interventions Not Available Not Available unknown_status NCT01774357 Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems No drug interventions Not Available Not Available completed NCT02342444 Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) prevention 4 recruiting NCT06238115 Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair treatment 2 / 3 recruiting NCT01557725 Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. No drug interventions Not Available Not Available completed NCT02052544 Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device No drug interventions Not Available Not Available completed NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients Not Available Not Available completed NCT06100380 Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants No drug interventions Not Available Not Available completed NCT06177704 Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study No drug interventions Not Available Not Available not_yet_recruiting NCT03244267 App Reminder on ASA Adherence No drug interventions other Not Available completed NCT02444572 Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® prevention 4 completed